Friday, November 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Monroe Capital NASDAQ MRCC Quarterly Earnings Report and Future Projections

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finance_Accounting
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Monroe Capital (NASDAQ: MRCC) is gearing up to unveil its latest quarterly earnings report on March 11, 2024. Market analysts are predicting an earnings per share (EPS) of $0.27 for the company. Investors are eagerly awaiting to see if Monroe Cap will exceed this projection and offer optimistic guidance for the following quarter, as such guidance often has a greater impact on stock prices than earnings surpasses or misses.

Looking back at Monroe Cap’s past performance:
– Q3 2023: EPS Estimate 0.27, EPS Actual 0.25, Price Change % 1.0%
– Q2 2023: EPS Estimate 0.28, EPS Actual 0.28, Price Change % -4.0%
– Q1 2023: EPS Estimate 0.27, EPS Actual 0.32, Price Change % 2.0%
– Q4 2022: EPS Estimate 0.26, EPS Actual 0.26, Price Change % -1.0%

On March 7, Monroe Cap’s shares were trading at $7.4, reflecting a decrease of 6.15% over the past year. Shareholders with a long-term view may be feeling uneasy about these negative returns leading up to the impending earnings announcement.

For additional insights into Monroe Capital’s earnings track record and future projections, you can check out their earnings calendar on various financial platforms.

Medley Capital Corporation (MRCC) Shows Slight Increase in Price Momentum on March 8, 2024

On March 8, 2024, Medley Capital Corporation (MRCC) had a relatively stable trading day, with the stock showing a slight increase in price momentum. The price of MRCC shares increased by $0.00 since the market last closed, representing a modest 0.06% rise. The stock opened at $7.46, which was $0.06 higher than its previous close. Overall, MRCC’s performance on March 8th was characterized by a slight uptick in price momentum, indicating a potentially positive trend for the stock.

MRCC Stock Shows Strong Revenue Growth and Improved EPS in Q3 2024

On March 8, 2024, MRCC stock showed significant improvements in its financial performance compared to the previous year and quarter. According to data from CNN Money, the company reported a total revenue of $55.55 million over the past year, which marks a 73.51% increase from the previous year. In the third quarter alone, MRCC generated $15.67 million in total revenue, representing a substantial 172.15% increase from the previous quarter.

Despite the impressive revenue growth, MRCC reported a net income of -$2.79 million over the past year, reflecting a 108.58% decrease from the previous year. However, in the third quarter, the company managed to reduce its net loss to -$236.00 thousand, indicating a 94.56% improvement from the previous quarter.

In terms of earnings per share (EPS), MRCC reported a negative EPS of -$0.13 over the past year, which represents a 108.5% decrease from the previous year. However, in the third quarter, the company’s EPS improved to -$0.01, marking a 94.55% increase from the previous quarter.

Overall, MRCC’s stock performance on March 8, 2024, demonstrated significant improvements in revenue generation and net income compared to the previous year and quarter. While the company still reported a net loss, the positive trends in revenue growth and EPS improvement indicate potential for future profitability and shareholder value. Investors may want to keep an eye on MRCC as it continues to navigate its financial performance and strategic initiatives in the market.

Tags: MRCC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Robotics Stock Market Today

Anticipating PLAYSTUDIOSs Quarterly Earnings Report A Look at Past Performance and Stock Trends

Finance_Fiscal (3)

Insider Confidence Board Member Shows Faith in California Water Service Group

Electric Utilities Stock Exchange

Board Member of California Water Service Group Demonstrates Confidence Through Investment

Recommended

USMC stock news

Barrow Hanley Mewhinney & Strauss LLC Increases Holdings in OFG Bancorp, Reinforcing Confidence in Financial Sector Growth

2 years ago
Crown Stock

Mixed Signals for Packaging Giant Crown as Insiders Sell Despite Strong Results

3 months ago
Varonis Stock

Varonis Stock Positioned for Growth Amid AI and Cloud Expansion

2 months ago
RCI Hospitality Stock

RCI Hospitality Shares Face Sustained Decline Amid Earnings Disappointment

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Diginex Shares Plunge as Bearish Momentum Intensifies

Silver’s Sharp Decline: A Critical Juncture for the Precious Metal

Amicus Therapeutics Reaches Profitability Milestone in Q3

Can Diodes’ Automotive Focus Reverse Its Stock Decline?

Broadcom Shares: Poised for a Pre-Earnings Rally?

EPR Properties: A Contrarian Opportunity Amid Market Divergence?

Trending

Xencor Stock
Pharma & Biotech

Xencor Shares Show Renewed Promise as Biotech Specialist Stages Recovery

by Dieter Jaworski
November 21, 2025
0

After experiencing significant pressure earlier this year, biotechnology firm Xencor is demonstrating a notable resurgence. The company's...

InnoCan Pharma Stock

InnoCan Pharma’s Breakthrough Study Fuels Nasdaq Ambitions

November 21, 2025
Nestle Stock

Nestlé’s Strategic Shift: Finance Takes the Helm

November 21, 2025
Diginex Stock

Diginex Shares Plunge as Bearish Momentum Intensifies

November 21, 2025
Silber Preis Stock

Silver’s Sharp Decline: A Critical Juncture for the Precious Metal

November 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Xencor Shares Show Renewed Promise as Biotech Specialist Stages Recovery
  • InnoCan Pharma’s Breakthrough Study Fuels Nasdaq Ambitions
  • Nestlé’s Strategic Shift: Finance Takes the Helm

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com